The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities
NAR Cancer · 07.10.2025 · 7 (4)
DOI: 10.1093/narcan/zcaf056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NAR Cancer, online erschienen am 31.12.2025. Verfasst von Daniela Muoio und 1 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Hillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, United …. Hauptthemen laut MEDLINE: DNA Repair, Telomere Homeostasis, Neoplasms, Telomere. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, UPMC Hillman Cancer Center.
Abstract (Originalsprache)
The alternative lengthening of telomeres (ALT) pathway is a telomerase-independent telomere maintenance mechanism leveraged by a subset of human cancers. In these tumors, telomere DNA synthesis is achieved via homologous recombination-based mechanisms. ALT-positive tumors harbor distinctive hallmarks, including heterogeneous telomere lengths, the presence of ALT-associated PML bodies, extrachromosomal telomeric repeats, telomere fragility, and mitotic DNA synthesis. These features reflect underlying replication stress and deregulated DNA repair mechanisms. ALT is associated with various tumor types and can often contribute to worsening the patient’s prognosis. Strikingly, ALT cancers are particularly enriched in childhood cancers, especially in high-grade gliomas, neuroblastoma, and osteosarcomas, three cancer types that are very common in children. Here, we provide a comprehensive review of the DNA repair factors that drive ALT activation and maintenance and explore emerging therapeutic opportunities associated with the selective dependence of ALT cancer cells on these specific DNA damage response factors. We aim to promote a growing interest in deciphering the DNA-repair-dependent mechanisms of ALT, ultimately helping to build a foundation for the discovery of novel therapeutics against aggressive ALT tumors, for which prognosis is particularly poor and treatments are currently severely lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- UPMC Hillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, United States.
ORCID-Profile: Elise Fouquerel
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- UPMC Hillman Cancer Center
Zitieren
APA
Muoio, D., & Fouquerel, E. (2025). The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities. NAR Cancer, 7(4). https://doi.org/10.1093/narcan/zcaf056
Vancouver
Muoio D, Fouquerel E. The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities. NAR Cancer. 2025;7(4). doi:10.1093/narcan/zcaf056
BibTeX
@article{Muoio2025,
author = {Muoio, Daniela and Fouquerel, Elise},
title = {The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities},
journal = {NAR Cancer},
year = {2025},
volume = {7},
number = {4},
doi = {10.1093/narcan/zcaf056}
}
EUVIMED